Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
Condition: Ureteral Injury,Interventions: Drug: sodium fluorescein; Drug: phenazopyridineSponsors: University Hospital Case Medical Center; Megan Billow; Graham Chapman; Sangeeta Mahajan; Alex Soriano; Sherif El-NasharNot yet recruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2016 Category: Research Source Type: clinical trials